Brain-Derived Neurotrophic Factor and Antidepressive Effect of Electroconvulsive Therapy: Systematic Review and Meta-Analyses of the Preclinical and Clinical Literature
Open Access
- 3 November 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (11) , e0141564
Abstract
Emerging data suggest that Electro-Convulsive Treatment (ECT) may reduce depressive symptoms by increasing the expression of Brain-Derived Neurotrophic Factor (BDNF). Yet, conflicting findings have been reported. For this reason we performed a systematic review and meta-analysis of the preclinical and clinical literature on the association between ECT treatment (ECS in animals) and changes in BDNF concentrations and their effect on behavior. In addition, regional brain expression of BDNF in mouse and human brains were compared using Allen Brain Atlas. ECS, over sham, increased BDNF mRNA and protein in animal brain (effect size [Hedge’s g]: 0.38―0.54; 258 effect-size estimates, N = 4,284) but not in serum (g = 0.06, 95% CI = -0.05―0.17). In humans, plasma but not serum BDNF increased following ECT (g = 0.72 vs. g = 0.14; 23 effect sizes, n = 281). The gradient of the BDNF increment in animal brains corresponded to the gradient of the BDNF gene expression according to the Allen brain atlas. Effect-size estimates were larger following more ECT sessions in animals (r = 0.37, P < .0001) and in humans (r = 0.55; P = 0.05). There were some indications that the increase in BDNF expression was associated with behavioral changes in rodents, but not in humans. We conclude that ECS in rodents and ECT in humans increase BDNF concentrations but this is not consistently associated with changes in behavior.Keywords
This publication has 83 references indexed in Scilit:
- Overweight and obesity are associated with neuronal injury in the human cerebellum and hippocampus in young adults: a combined MRI, serum marker and gene expression studyTranslational Psychiatry, 2012
- Serum BDNF Concentrations Show Strong Seasonal Variation and Correlations with the Amount of Ambient SunlightPLOS ONE, 2012
- BDNF val66met affects hippocampal volume and emotion-related hippocampal memory activityTranslational Psychiatry, 2012
- Circulating and Brain BDNF Levels in Stroke Rats. Relevance to Clinical StudiesPLOS ONE, 2011
- Brain Derived Neurotrophic Factor (BDNF) Expression Is Regulated by MicroRNAs miR-26a and miR-26b Allele-Specific BindingPLOS ONE, 2011
- Spatial segregation of BDNF transcripts enables BDNF to differentially shape distinct dendritic compartmentsProceedings of the National Academy of Sciences, 2011
- Cerebral 5-HT2A Receptor and Serotonin Transporter Binding in Humans Are Not Affected by the val66met BDNF Polymorphism Status or Blood BDNF LevelsJournal of Cerebral Blood Flow & Metabolism, 2010
- A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortexHuman Molecular Genetics, 2008
- Performance of the trim and fill method in the presence of publication bias and between‐study heterogeneityStatistics in Medicine, 2007
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002